ETH Zürich

ETH Zürich (Swiss Federal Institute of Technology in Zürich) is an engineering, science, technology, mathematics and management university in the city of Zürich, Switzerland. Founded by the Swiss Federal Government in 1854, ETH Zürich has the stated mission to educate engineers and scientists, serve as a national center of excellence in science and technology and provide a hub for interaction between the scientific community and industry. ETH Zürich is consistently ranked among the top universities in the world, and is currently ranked as 3rd best university in the world in engineering, science and technology.


Professor deMello is currently Chairman of the Institute of Chemical and Bioengineering (ICB) at ETH Zürich. The ICB is home to over 250 scientists and engineers working on a broad range of topics including, chemical aspects of energy, heterogeneous catalysis, colloid engineering, biotechnology, bioengineering and microfluidics. The institute is responsible for all undergraduate teaching in Chemical Engineering (Bachelors and Masters level) and trains over 150 PhD students at any one time. Additionally, Professor deMello is an Associated Group Head at the MRC Clinical Sciences Centre at Imperial College London collaborating with a diversity of cell biologists to develop new technologies for stem cell reprogramming. Between 2005 and 2011 Professor deMello was a lead investigator on the £5M EPSRC Single Cell Proteomics initiative at Imperial College London.

In the Teaming project ETH Zürich and RECETOX will together focus on development and application of novel microfluidic platforms for high-throughput imaging cytometry, combinatorial biological assays and high-throughput microfluidic single- cell screening/sorting platforms.

Key people

prof. Andrew deMello



Dr. Stavros Stavrakis

Senior Scientist


prof. Martin Scheringer



Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.

Další info